APP
TMCI icon

Alpha Paradigm Partners’s Treace Medical Concepts TMCI Stock Holding History

Alpha Paradigm Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-37,130
Closed -$692K – 682
2021
Q4 		$692K Buy
+37,130
New +$766K 0.28% 104

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alpha Paradigm Partners's TMCI Position: Q1 2022 in Review

Alpha Paradigm Partners sold out of Treace Medical Concepts (TMCI) in Q1 2022, closing a stake of 37,130 shares — an estimated $692K sold.

Alpha Paradigm Partners first reported a position in TMCI in Q4 2021 and held it in 1 quarter. The position peaked at $692K in Q4 2021. 75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

  • Alpha Paradigm Partners reported no remaining Treace Medical Concepts position as of Q1 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 37,130 Treace Medical Concepts shares in Q1 2022, an estimated $692K.
  • Alpha Paradigm Partners first reported a position in Treace Medical Concepts in Q4 2021 and held it in 1 quarter.
  • Alpha Paradigm Partners's Treace Medical Concepts position peaked at $692K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on Alpha Paradigm Partners's 13F filing for Q1 2022, filed 16 May 2022.